Chemotherapy With DNA Damaging Agents In Colorectal Cancer

Centro Hospitalar Nordeste

Status and phase: Completed; Phase 1

Conditions: Colorectal Cancer

Treatments: Other: Only chemotherapy treatment for study cohort; Procedure: surgery; Other: Treatment with chemotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01456923

ACCRC10

Details and patient eligibility

About

Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.

Sex: All

Ages: 40 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients that did not underwent surgery

Exclusion criteria

• patients that underwent surgery

Trial design

0 participants in 2 patient groups

Control (chemotherapy and surgery)

Active Comparator group

Description:

Patients treated with chemotherapy + surgery

Treatment:

Procedure: surgery

Other: Treatment with chemotherapy

Study

Active Comparator group

Description:

Patients treated only with chemotherapy

Treatment:

Other: Only chemotherapy treatment for study cohort